Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Selected Balance Sheet Data

v3.21.2
Note 3 - Selected Balance Sheet Data
3 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Supplemental Balance Sheet Disclosures [Text Block]

Note 3. Selected Balance Sheet Data:

 

Inventories:

 

Inventories consist of (in thousands):

 

   

September 30,

   

June 30,

 
   

2021

   

2021

 

Raw materials

  $ 58,001     $ 55,096  

Finished goods(1)

    64,740       67,108  

Inventories, net

  $ 122,741     $ 122,204  

 

(1Finished goods inventory of $5,375 and $5,456 included within other long-term assets in the respective September 30, 2021 and June 30, 2021, consolidated balance sheet. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date.  

 

Property and Equipment:

 

Property and equipment consist of (in thousands):

 

   

September 30,

   

June 30,

 
   

2021

   

2021

 

Land

  $ 8,586     $ 8,612  

Buildings and improvements

    191,284       190,661  

Machinery and equipment

    202,792       198,483  

Property and equipment, cost

    402,662       397,756  

Accumulated depreciation and amortization

    (195,528

)

    (189,849

)

Property and equipment, net

  $ 207,134     $ 207,907  

 

Intangible Assets:

 

Intangible assets consist of (in thousands):

 

   

September 30,

   

June 30,

 
   

2021

   

2021

 

Developed technology

  $ 551,289     $ 552,160  

Trade names

    147,245       147,640  

Customer relationships

    230,695       232,493  

Patents 

    2,989       2,926  
Other intangibles     6,309       6,316  

Definite-lived intangible assets

    938,527       941,535  

Accumulated amortization

    (364,927

)

    (348,267

)

Definite-lived intangibles assets, net     573,600       593,268  
In process research and development     22,700       22,700  
Total intangible assets, net   $ 596,300     $ 615,968  

 

 

 

 

Changes to the carrying amount of net intangible assets for the quarter ended September 30, 2021 consist of (in thousands):

 

Beginning balance

  $ 615,968  

Acquisitions

    -  

Other additions

    43  

Amortization expense

    (18,606

)

Currency translation

    (1,105 )

Ending balance

  $ 596,300  

 

The estimated future amortization expense for intangible assets as of September 30, 2021 is as follows (in thousands):

 

2022 remainder

  $ 55,714  

2023

    72,454  

2024

    69,618  

2025

    66,372  

2026

    62,606  

Thereafter

    246,836  

Total

  $ 573,600  

 

Goodwill:

 

Changes to the carrying amount of goodwill for the quarter ended September 30, 2021 consist of (in thousands):

 

   

Protein Sciences

   

Diagnostics and

Genomics

   

Total

 

Beginning balance

  $ 392,717       450,350     $ 843,067  

Currency translation

    (2,979 )     (68 )     (3,047 )

Ending balance

  $ 389,738     $ 450,282     $ 840,020  

 

We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a quantitative goodwill impairment assessment for all of its reporting units during the fourth quarter of fiscal 2021. No indicators of impairment were identified as part of our assessment. 

 

During the quarter ended September 30, 2021, the Company combined the management of the Exosome and Asuragen reporting units, both of which are included in the Diagnostics and Genomics operating segment. In conjunction with the combination of the reporting units, a qualitative goodwill impairment assessment was performed. The qualitative assessment identified no indicators of impairment. No triggering events or items beyond the reporting unit combination that would require a goodwill impairment assessment were identified during the quarter ended September 30, 2021. There has been no impairment of goodwill since the adoption of Financial Accounting Standards Board (“FASB”) ASC 350 guidance for goodwill and other intangibles on July 1, 2002.